AJP - Endo Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 289: E241-E250, 2005. First published March 1, 2005; doi:10.1152/ajpendo.00587.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/2/E241    most recent
00587.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruzzin, J.
Right arrow Articles by Jensen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruzzin, J.
Right arrow Articles by Jensen, J.

Contraction activates glucose uptake and glycogen synthase normally in muscles from dexamethasone-treated rats

Jérôme Ruzzin1,2 and Jørgen Jensen1

1Department of Physiology, National Institute of Occupational Health; and 2Norwegian University of Sport and Physical Education, Oslo, Norway

Submitted 10 December 2004 ; accepted in final form 21 February 2005

Glucocorticoids cause insulin resistance in skeletal muscle. The aims of the present study were to investigate the effects of contraction on glucose uptake, insulin signaling, and regulation of glycogen synthesis in skeletal muscles from rats treated with the glucocorticoid analog dexamethasone (1 mg·kg–1·day–1 ip for 12 days). Insulin resistance in dexamethasone-treated rats was confirmed by reduced insulin-stimulated glucose uptake (~35%), glycogen synthesis (~70%), glycogen synthase activation (~80%), and PKB Ser473 phosphorylation (~40%). Chronic dexamethasone treatment did not impair glucose uptake during contraction in soleus or epitrochlearis muscles. In epitrochlearis (but not in soleus), the presence of insulin during contraction enhanced glucose uptake to similar levels in control and dexamethasone-treated rats. Contraction also increased glycogen synthase fractional activity and dephosphorylated glycogen synthase at Ser645, Ser649, Ser653, and Ser657 normally in muscles from dexamethasone-treated rats. After contraction, insulin-stimulated glycogen synthesis was completely restored in epitrochlearis and improved in soleus from dexamethasone-treated rats. Contraction did not increase insulin-stimulated PKB Ser473 or glycogen synthase kinase-3 (GSK-3) phosphorylation. Instead, contraction increased GSK-3{beta} Ser9 phosphorylation in epitrochlearis (but not in soleus) in muscles from control and dexamethasone-treated rats. In conclusion, contraction stimulates glucose uptake normally in dexamethasone-induced insulin resistant muscles. After contraction, insulin's ability to stimulate glycogen synthesis was completely restored in epitrochlearis and improved in soleus from dexamethasone-treated rats.

insulin signaling; glycogen synthase kinase-3; protein kinase B; glucocorticoids; AMP-activated protein kinase



Address for reprint requests and other correspondence: J. Jensen, Dept. of Physiology, National Institute of Occupational Health, PO Box 8149 Dep., N-0033, Oslo, Norway (e-mail: jorgen.jensen{at}stami.no)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y.-C. Lai, J. T. Stuenaes, C.-H. Kuo, and J. Jensen
Glycogen content and contraction regulate glycogen synthase phosphorylation and affinity for UDP-glucose in rat skeletal muscles
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1622 - E1629.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S. Bose, M A. Farah, H.-C. Jung, J.-H. Lee, and Y. Kim
Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone
J. Mol. Endocrinol., June 1, 2007; 38(6): 627 - 649.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.